Get the Stockscreener App
28.50
0.46%
0.13
After Hours:
28.50
Amphastar Pharmaceuticals Inc stock is traded at $28.50, with a volume of 455.55K.
It is up +0.46% in the last 24 hours and down -9.50% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$28.37
Open:
$28.37
24h Volume:
455.55K
Relative Volume:
0.78
Market Cap:
$1.36B
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
9.50
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
+2.11%
1M Performance:
-9.50%
6M Performance:
-40.65%
1Y Performance:
-34.51%
1-Day Range:
$28.26
$28.75
1-Week Range:
$27.66
$28.83
52-Week Range:
$25.89
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
28.50 | 1.36B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
165.02 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.14 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.49 | 17.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.75 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Quantbot Technologies LP Buys Shares of 25,454 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat
Fox Run Management L.L.C. Makes New $688,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World
Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Amundi - MarketBeat
Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 0.46% on Mar 19 - GuruFocus.com
US Bancorp DE Has $31,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
(AMPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
On Nasdaq, I Prefer The Less-Famous Stocks - Forbes
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowTime to Sell? - MarketBeat
Wealthfront Advisers LLC Acquires New Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Smartleaf Asset Management LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks | FinancialContent - Financial Content
Amphastar stock hits 52-week low at $26.97 amid market challenges - Investing.com Australia
Amphastar at Barclays Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Amphastar stock hits 52-week low at $26.97 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 4,231 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
(AMPH) Proactive Strategies - Stock Traders Daily
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock - Investing.com India
Amphastar Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Amphastar Pharmaceuticals CFO sells $116,515 in stock By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals CFO sells $116,515 in stock - Investing.com
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference - ACCESS Newswire
Will Amphastar Reveal New Strategic Insights at Upcoming Barclays Healthcare Conference? - StockTitan
17,049 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Illumine Investment Management LLC - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 52-Week LowHere's What Happened - MarketBeat
Amphastar Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsAMPH - ACCESS Newswire
Amphastar’s Earnings Call: Growth Amid Challenges - TipRanks
Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results - MarketBeat
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.46%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):